E. Clerici

发表

Soluble CD30, tumour necrosis factor (TNF)-alpha, and TNF receptors in primary HIV-1 infection: relationship with HIV-1, RNA, clinical outcome and early antiviral therapy.

G. Pantaleo, A. Lazzarin, W. Barcellini, 1997, Journal of Biological Regulators and Homeostatic Agents.

Multiple defects of T helper cell function in newly diagnosed patients with Hodgkin's disease.

D. Venzon, M. Clerici, G. Shearer, 1994, European journal of cancer.

Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy

M. Clerici, D. Trabattoni, M. L. Villa, 1996, Clinical and experimental immunology.

Some Aspects of Immunity in Tumors.

E. Clerici, 1965, Tumori.

Increased plasma levels of the C-C chemokine RANTES in patients with primary HIV-1 infection.

A. Lazzarin, M. Algeri, L. Furci, 1997, Journal of biological regulators and homeostatic agents.

The interference of antibiotics with antigen-specific antibody responses in man.

P. Piazza, G. Rappocciolo, M. Villa, 1986, International journal of immunopharmacology.

Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.

D. Venzon, M. Clerici, G. Shearer, 1997, Journal of the National Cancer Institute.

Monocyte mediated modulation of the antibody response in vitro.

P. Piazza, G. Rappocciolo, M. Villa, 1985, Immunology letters.

Immunological aspects of amyloidosis.

C. Porta, A. Pessina, G. Garotta, 1973, Israel journal of medical sciences.

The tumor enhancement phenomenon: reinterpretation from a Th1/Th2 perspective.

M. Clerici, G. Shearer, E. Clerici, 1996, Journal of the National Cancer Institute.

Foetal liver stem cells inhibition by Ehrlich ascites carcinoma.

C. Porta, P. Mocarelli, G. Garotta, 1973, Advances in experimental medicine and biology.

Influence of Ehrlich ascites carcinoma on repopulating ability of mouse bone marrow cells.

P. Mocarelli, N. Natale, M. Villa, 1971, Journal of the National Cancer Institute.

Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis.

M. Clerici, G. Aversa, J. D. de Vries, 1998, Journal of immunology.

Acute Multiple Sclerosis Molecule (SLAM)-Expressing Lymphocytes in Augmented Signaling Lymphocytic Activation Sclerosis: Altered IL-12 Production and Expression in Acute and Stable Multiple Cytokine Production and Surface Marker

M. Clerici, G. Aversa, M. Biasin, 1998 .

Comparison of pathologic and normal sera by immune complex determination: five disease groups within 190 samples are discriminated by computer-selected combinations of 13 methods. Report of the Italian committee for the study of immune complexes (WIC).

R. Coppo, S. Bombardieri, P. Migliorini, 1984, Clinical immunology and immunopathology.

An assay for estradiol receptors using a staphylococcal protein‐a — estradiol antibody adsorbent

G. di Fronzo, E. Clerici, E. Ronchi, 1979 .

Immunoadherence and complement in cancer-bearing mice.

C. Porta, M. Villa, E. Clerici, 1978, British Journal of Cancer.

Immunocomplexes in normal blood donors and in melanoma patients

M. Lodola, E. Clerici, C. Masserini, 1981 .

T-cell precursors in mice bearing the Ehrlich ascites tumors.

C. Porta, P. Mocarelli, G. Garotta, 1976, Journal of the National Cancer Institute.

Reversibility of the immunodepression due to Ehrlich ascites carcinoma.

C. Porta, P. Mocarelli, G. Garotta, 1973, Journal of immunology.

Enrichment of suppressor cell activity by hydrocortisone: Suppression of in vitro activation of splenocytes from mice bearing lewis lung carcinoma

M. Feldman, E. Clerici, Bilha Schechter, 1980, International journal of cancer.

Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: time to consider the TH1/TH2 paradigm.

M. Clerici, G. Shearer, E. Clerici, 1998, Journal of the National Cancer Institute.

Antibody production in cultured blood lymphocytes from breast cancer patients.

M. Migliori, M. Villa, E. Clerici, 1983, British Journal of Cancer.

Antibody production incultured bloodlymphocytes from breast cancerpatients

M. Migliori, M. Villa, E. Clerici, 1983 .

Reduced natural killer cell activity and IL-2 production in malnourished cancer patients.

L. Cozzaglio, M. Villa, E. Ferrario, 1991, British Journal of Cancer.

Antibody-forming foci in soft-agar cultures of human peripheral blood cells.

M. Villa, E. Clerici, Maria Luisa Villa, 1981, Journal of immunological methods.

Macrolidic antibiotics: effects on primary in vitro antibody responses.

F. Scaglione, M. Mantovani, M. Villa, 1988, International journal of immunopharmacology.

Influence of sex steroids on the antigen-specific primary antibody response in vitro.

M. Villa, E. Ferrario, E. Clerici, 1991, Journal of clinical & laboratory immunology.

Distinct antigenic specificities of alanine peptide determinants attached to protein carriers via terminal amino or carboxyl groups.

I. Schechter, E. Clerici, E. Zakepitzki, 1971, European journal of biochemistry.

Poly-DL-alanyl skin isograft rejection by purified anti-poly-DL-alanyl antibodies.

M. Villa, E. Clerici, A. Marocchi, 2008, Tissue antigens.